Resistance Exercise in Hemodialysis Patients
REHDP
The Impact of Resistance Exercise on Symptom Burden in Older Patients Undergoing Maintenance Hemodialysis
1 other identifier
interventional
54
0 countries
N/A
Brief Summary
The goal of this clinical trial is to learn if an intradialytic resistance exercise intervention works to reduce the symptom burden in older maintenance hemodialysis patients. It will also learn about safety of the intradialytic resistance exercise intervention program. The main questions it aims to answer are:
- 1.Does intradialytic resistance exercise effectively improve the number, frequency, and severity of symptoms in older patients?
- 2.What adverse events may occur among older dialysis patients during exercise?
- 3.Take an intradialytic resistance exercise intervention program developed through joint decision-making by rehabilitation experts, dialysis center physicians, nurses, and patients, conducted three times a week for 20 minutes each session, over a duration of three months.
- 4.Visit the hospital a monthly for texts and examinations.
- 5.Keep a diary of the types and frequency of adverse events during and after the exercise sessions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 2, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
October 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2025
CompletedSeptember 19, 2024
September 1, 2024
3 months
September 2, 2024
September 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dialysis Symptom Index
Kidney failure-related symptoms were assessed every month using the dialysis symptom index (DSI), a previously validated questionnaire Through this questionnaire, patients indicated the presence of 30 symptoms in the past month, resulting in a total sum score for symptom number ranging from 0 to 30. Additionally, for each symptom present, patients rated symptom burden on a five-point Likert scale, ranging from one for "not at all" to five for "very much" burdensome. Absent symptoms were assigned a score of zero, resulting in an overall symptom burden score ranging from zero to 150, with higher scores indicating larger burden.
From enrollment to the end of treatment at 12 weeks
Secondary Outcomes (3)
30 Seconds Sit To Stand Test
From enrollment to the end of treatment at 12 weeks
Short Physical Performance Battery
From enrollment to the end of treatment at 12 weeks
Number of participants with abnormal laboratory tests results
From enrollment to the end of treatment at 12 weeks
Study Arms (2)
Resistance Exercise Intervention Group
EXPERIMENTALResistance exercise intervention plan, developed through expert meetings and integrated review summaries, consists of 27 items including: participant preparation, team preparation, exercise prescription FITT-VP, process monitoring, discontinuation criteria, termination criteria, recovery methods, outcome measures, and special considerations.
control group
ACTIVE COMPARATORRoutine care
Interventions
The exercise prescription, developed through expert meetings and integrated review summaries, consists of 27 items including: participant preparation, team preparation, exercise prescription FITT-VP, process monitoring, discontinuation criteria, termination criteria, recovery methods, outcome measures, and special considerations.
1.Pre-dialysis Assessment: 1. Vital Signs: Monitor blood pressure, heart rate, temperature. 2. Access Care: Check the vascular access site for signs of infection and patency. 2.During Dialysis: (1)Monitoring: Continuous vital signs and machine settings monitoring. (2)Fluid Management: Control fluid removal based on pre-dialysis weight. 3.Post-dialysis Care: 1. Observation: Monitor for complications like hypotension, cramps, or bleeding. 2. Weight Check: Weigh post-dialysis to verify fluid removal. 4.Education and Support: (1)Diet: Educate on dietary restrictions (potassium, phosphorus, fluids). (2)Medications: Advise on medication adjustments. 5.Psychosocial Support: (1)Provide emotional support and counseling.
Eligibility Criteria
You may qualify if:
- Age 60 years and above Stable on dialysis for ≥3 months Able to walk independently, no physical disability, and muscle strength ≥ Grade III Capable of understanding and complying with the requirements of this study Voluntarily signed an informed consent form
You may not qualify if:
- Severe cardiovascular, cerebrovascular, respiratory, or neurological diseases, or other conditions that impair physical ability to exercise Serious infections, bleeding, trauma, or other conditions affecting physical status within the last 3 months Severe mental disorders or cognitive impairments Abnormal blood pressure (pre-dialysis systolic pressure ≥180mmHg, diastolic pressure ≥100mmHg) Hemoglobin (Hb) \< 90g/L, Albumin (Alb) ≤ 32g/L Participation in other exercise or pharmacological interventions in the past 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Teng Zenglead
- Shengjing Hospitalcollaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Graduate student
Study Record Dates
First Submitted
September 2, 2024
First Posted
September 19, 2024
Study Start
October 3, 2024
Primary Completion
January 3, 2025
Study Completion
March 3, 2025
Last Updated
September 19, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share
1. Privacy Concerns: To protect participant privacy and confidentiality, given the sensitive nature of the data. 2. Research Integrity: To maintain the integrity of the research and prevent potential misuse of the data outside the specific study objectives. 3. Personal Decision: To retain control over data usage and ensure adherence to ethical standards and research protocols established for this study.